Antioxidant intervention blunts renal injury in experimental renovascular disease

Alejandro R Chade1, Martin Rodriguez-Porcel, Joerg Herrmann

  • 1Department of Internal Medicine, Division of Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Insights

Antioxidant vitamins C and E improved kidney function and reduced injury in experimental renovascular disease (RVD). This highlights oxidative stress

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Oxidative Stress and Inflammation

Background:

  • Atherosclerotic renovascular disease (RVD) exacerbates kidney damage through inflammation and impaired tissue remodeling.
  • Increased oxidative stress is implicated in RVD, but its direct role in renal injury requires further elucidation.

Purpose of the Study:

  • To investigate the hypothesis that chronic antioxidant intervention in RVD can improve renal function and reduce tissue injury.
  • To assess the impact of antioxidant supplementation on hemodynamics, inflammatory markers, and fibrotic processes in experimental RVD.

Main Methods:

  • Experimental renovascular disease (RVD) was induced in pigs via hypercholesterolemia and renal artery stenosis.
  • Groups included RVD, RVD with antioxidant vitamins C and E (RVD+Vitamins), and controls.
  • Hemodynamics and function were assessed using electron-beam computed tomography; renal tissue was analyzed via Western blot and immunohistochemistry.

Main Results:

  • RVD+Vitamins showed improved renal blood flow and glomerular filtration rate responses to acetylcholine compared to RVD alone.
  • Antioxidant treatment decreased markers of oxidative stress (NAD(P)H-oxidase, nitrotyrosine) and inflammation (NF-kappaB, iNOS).
  • RVD+Vitamins exhibited reduced pro-fibrotic factors and enhanced protein degradation, leading to attenuated glomerulosclerosis and fibrosis.

Conclusions:

  • Chronic antioxidant intervention in early experimental RVD enhances renal functional recovery and reduces structural damage.
  • The findings support a significant role for oxidative stress in RVD-induced renal injury and scarring.
  • Antioxidant strategies may be beneficial in preserving kidney health in atherosclerotic and ischemic conditions.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...